首页 >
法规速递
-
Regulatory and procedural guideline: ICH guideline Q3C (R8) on impurities: guideline for residual solvents - Step 5-2022/11/28
2022-11-30查看详情 > -
Final Guidance: Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals-2023/6/2
2023-06-05查看详情 > -
国家药监局关于适用《Q13：原料药和制剂的连续制造》国际人用药品注册技术协调会指导原则的公告（2023年第158号）-2023/12/14
2023-12-21查看详情 > -
Document: European Medicines Agency Write PMS API implementation Guide (zip)-2025/1/21
2025-01-22查看详情 > -
Page: Clinical Trials Information System (CTIS): training and support-2025/2/24
2025-02-25查看详情 > -
Document: Start of procedure: Type II variation - extension of indication under evaluation by the CHMP (28 February 2025 - 27 March 2025)-2025/4/1
2025-04-02查看详情 > -
Document: Agenda - EMA’s 30th anniversary scientific conference-2025/5/12
2025-05-13查看详情 > -
Document: Superseded Community herbal monograph on Zingiber officinale Roscoe, rhizoma-2025/6/19
2025-06-20查看详情 > -
Page: Pharmaceutical quality of inhalation and nasal products - Scientific guideline-2025/7/24
2025-07-25查看详情 > -
Classification Categories for Certain Supplements Under BsUFA III-2025/9/8
2025-09-09查看详情 >
